Table 2.
Pathological characterization of gastric carcinoma patients in correlation with Hpa2 staining intensity.
| HPA2 |
|||||
|---|---|---|---|---|---|
| Total | Low (%) | High (%) | χ2 value | P value | |
| Gendera | |||||
| Male | 101 | 57 (56) | 44 (44) | ||
| Female | 33 | 21 (63) | 12 (37) | 0.53 | 0.4 |
| Age | |||||
| <65 | 62 | 27 (43) | 35 (57) | ||
| ≥65 | 73 | 52 (71) | 21 (29) | 10.585 | 0.001 |
| Volumeb | |||||
| <5cm | 54 | 24 (44) | 30 (56) | ||
| ≥5cm | 77 | 52 (67) | 25 (33) | 6.946 | 0.008 |
| Tc | |||||
| T1-T2 | 26 | 12 (46) | 14 (54) | ||
| T3-T4 | 95 | 57 (60) | 38 (40) | 1.597 | 0.2 |
| Na | |||||
| N1-N2 | 58 | 27 (46) | 31 (54) | ||
| N3-N4 | 76 | 51 (67) | 25 (33) | 5.713 | 0.01 |
| M | |||||
| M0 | 128 | 74 (57) | 54 (43) | ||
| M1 | 7 | 5 (71) | 2 (29) | 0.507 | 0.4 |
| Staged | |||||
| I-II | 54 | 26 (48) | 28 (52) | ||
| III-IV | 73 | 48 (65) | 25 (35) | 3.956 | 0.04 |
Hpa2 = heparanase 2.
a
Information on 1 patient was missing.
b
Information on 4 patients was missing.
c
Information on 14 patients was missing.
d
Information on 8 patients was missing.